Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 259 across all filing types
Latest filing 2022-03-30 Regulatory Filings
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release dated March 30, 2022, announcing the 'publication' of study results in a peer-reviewed journal (Orphanet Journal of Rare Disease) regarding their drug ADV7103. The text is short (under 5,000 characters) and its primary function is to inform the public that a report/paper has been released and provide a link to it. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the release or publication of company reports, rather than being the full report itself (like an ER or IR).
2022-03-30 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from Advicenne dated March 30, 2022, announcing the publication of a descriptive study regarding their drug ADV7103 in the journal 'Orphanet Journal of Rare Diseases'. This is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER) or a management discussion (MDA). It is an announcement about external research findings related to their product, which falls under general corporate or regulatory news. Since it is an announcement of a specific, non-financial regulatory/research event, and it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered elsewhere, especially those related to clinical/research updates being made public.
2022-03-30 French
Inside Information / Operations of the issuer (acquisitions, sales...)
Delisting Announcement Classification · 1% confidence The document is an announcement titled "Advicenne announces the transfer of its shares from Euronext Paris and Euronext Brussels to Euronext Growth Paris on March 30, 2022". This explicitly details a change in the company's stock exchange listing, which is a significant corporate action related to its capital structure or market presence. While it is an announcement, it is not a general regulatory filing (RNS) or a specific financing event (CAP). It is most closely related to a change in listing status, which often falls under capital structure changes or, in this context of market movement, can be seen as a specific corporate event announcement. However, none of the provided codes perfectly match 'Stock Exchange Transfer Announcement'. Given the options, a delisting from one market and listing on another is a major structural change. Since the document focuses entirely on the mechanics and date of this market transfer, and it is not a standard financial report, the closest fit among the provided codes that deals with structural changes is 'Capital/Financing Update' (CAP) or potentially 'Delisting Announcement' (DLST), although it's a dual move. Since the core event is the change of listing venue, which impacts how capital is traded, and it is not a standard delisting (as it immediately lists elsewhere), I will re-evaluate. The document is a press release announcing a corporate action regarding its stock listing venue. This is a significant corporate event. If we look at the definitions, 'DLST' is 'Delisting Announcement'. Since the company is delisting from Euronext Paris/Brussels, this code is highly relevant, even though it's immediately followed by a relisting on Euronext Growth. Given the specific nature of the announcement focusing on the delisting dates, DLST is the most precise fit among the provided codes for the primary action being communicated, even if it's a transfer. If DLST is too narrow, RNS would be the fallback. However, the event is a delisting from regulated markets. I will classify it as DLST due to the explicit mention of delisting dates, recognizing it's a transfer.
2022-03-28 English
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Delisting Announcement Classification · 1% confidence The document is a press release from Advicenne announcing the transfer of its stock listing from Euronext Paris/Bruxelles to Euronext Growth Paris, effective March 30, 2022. This announcement details a change in the company's listing status and associated administrative simplification. This type of corporate action announcement, which is not a standard periodic financial report (like 10-K or IR) or a specific event report (like ER or DIV), falls best under a general regulatory announcement or corporate action category. Since it is a formal announcement regarding a change in listing/capital structure context, it is most closely related to 'Share Issue/Capital Change' (SHA) or a general 'Regulatory Filing' (RNS). Given that the core event is the change in listing venue, which impacts capital market structure, SHA is a possibility, but the text focuses heavily on the administrative process and the regulatory notification aspect. Since there is no specific code for 'Listing Change Announcement', and it is a formal regulatory communication about a structural change, 'RNS' (Regulatory Filings - general fallback for miscellaneous filings) is the most appropriate fit, although 'SHA' (Share Issue/Capital Change) is a close secondary candidate due to the capital market context. Given the nature of the announcement (a formal notice of a listing transfer), RNS is chosen as the best fit for a non-standard, mandatory disclosure.
2022-03-28 French
Informations privilégiées / Autres communiqués
Delisting Announcement Classification · 1% confidence The document is a press release dated January 21, 2022, announcing that the Ordinary General Meeting of shareholders approved the project to transfer the listing of Advicenne's shares from the regulated market of Euronext Brussels to Euronext Growth Paris, and the concurrent delisting from Euronext Brussels. This announcement details a corporate action related to the company's listing venue and capital structure, which is a significant event for investors. While it discusses future financial reporting timelines (which might suggest an IR or AR context), the primary subject is the change in listing venue and the associated regulatory implications (like shareholder protection thresholds and reporting obligations under the new market). This type of announcement, concerning a change in listing status or significant corporate structure/financing event, best fits the 'Capital/Financing Update' category (CAP) or potentially a general 'Regulatory Filing' (RNS) if CAP is too narrow. Given the focus on the transfer of listing and the resulting changes in market structure, CAP is the most specific fit among the provided options, as listing changes are fundamentally capital/financing structure decisions. It is not a full 10-K, ER, or IR. It is an announcement of a corporate action, not a report itself, ruling out RPA/RNS based on the 'Menu vs Meal' rule if it were just announcing a report, but here it is announcing a major corporate transaction/change.
2022-01-21 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is a press release dated January 21, 2022, announcing that the ordinary shareholders' meeting approved the project to transfer the company's share listing from the regulated market of Euronext Paris to Euronext Growth Paris and simultaneously delist from Euronext Brussels. This announcement details a significant corporate action related to the capital structure and listing venue. While it discusses the consequences for financial reporting and shareholder protection, the core subject is the change in listing status, which is a form of capital/financing activity or a major corporate event. Since there is no specific code for 'Listing Change Announcement', the closest fit among the provided options that covers major structural/financing changes is 'Capital/Financing Update' (CAP). It is not a full 10-K, an ER, or a standard IR. It is an announcement of a decision regarding the company's listing structure, which impacts its capital market presence.
2022-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.